Potential clinical utility of dual time point FDG-PET for distinguishing benign from malignant lesions: implications for oncological imaging.
?
['Animals', 'Breast Diseases/diagnostic imaging', 'Breast Neoplasms/diagnostic imaging', 'Diagnosis, Differential', 'Female', '*Fluorine Radioisotopes/pharmacokinetics', '*Fluorodeoxyglucose F18/pharmacokinetics', 'Head and Neck Neoplasms/diagnostic imaging', 'Humans', 'Lung Diseases/diagnostic imaging', 'Lung Neoplasms/diagnostic imaging', 'Male', 'Neoplasms/*diagnostic imaging', 'Positron-Emission Tomography/*methods', '*Radiopharmaceuticals/pharmacokinetics', 'Tissue Distribution']